Bardy Diagnostics Stock

bardydx.comHealthcare / Medical DevicesFounded: 2013Funding to Date: $84.02MM

Bardy Diagnostics is the developer of a heart monitor known as Carnation Ambulatory Monitor (CAM™) that can be worn comfortably and discreetly for up to 14 days.

Register To Buy and Sell Shares

For more details on financing and valuation for Bardy Diagnostics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Bardy Diagnostics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Bardy Diagnostics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Mark Querry
Chief Financial Officer
Ken Nelson
Chief Commercial Officer
Gust Bardy MD
Founder, Chief Executive Officer, Chief Medical Officer and Chairman
Jonathan Wu
Director, Marketing
Alan Levy Ph.D
Executive Director
Edward Vertatschitsch Ph.D
Chief Operating Officer
Mark Handfelt
Chief Operating Officer

Board Members

David Tamburri
LaViolette Paul
Warren Watson
Garheng Kong MD
HealthQuest Capital
Rubal Bedi
Ascension Ventures
Gerry Brunk
Lumira Ventures
Gust Bardy MD
Rurik Vandevenne
River Cities Capital Funds

News Highlights

Bardy Diagnostics™ Names Ed Vertatschitsch as Chief Operating Officer and Announces Additions to the Leadership Team
/PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the...
Xconomy: Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise
Bardy Diagnostics, a Seattle-based business developing a cardiac monitor and arrhythmia detection device, announced this week it has raised $35.5 million
Updated on: May 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.